Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
Status:
NOT_YET_RECRUITING
Trial end date:
2028-02-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa